Preemption Trend Favors Pharma In Generic Reglan Fight

By Dan Packel, Originally published on Law 360  Pennsylvania plaintiffs should not draw too much hope from the state’s Supreme Court declining to address a lower court ruling that product liability claimsfrom users of generic Reglan weren’t necessarily preempted by federal law, as rulings in other venues have not been kind to claimants… [ Read More ]  

[polldaddy poll=8340057]


Upcoming Conference 


Be a Part of the Community at the Nation’s Premier Drug and Med Litigation Conference, and Stay on the Cutting Edge of Evolving Defense Strategies and Emerging Theories of Liability



To learn more and register, visit: